PCSA vs PHM · $5.9M cap vs P/E 7.7, rev $17.95B
Processa Pharmaceuticals Inc (PCSA) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported PCSA revenue for 2023-09-30 was $0. Net income was -$2.1M. PCSA currently screens at market cap $5.9M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
PCSA currently screens at market cap $5.9M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the PCSA and PHM stock pages for the full models.
Not investment advice.